A detailed history of Sentry LLC transactions in Novartis Ag stock. As of the latest transaction made, Sentry LLC holds 3,010 shares of NVS stock, worth $312,588. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,010
Previous 3,045 1.15%
Holding current value
$312,588
Previous $324 Million 6.8%
% of portfolio
0.07%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$106.13 - $120.89 $3,714 - $4,231
-35 Reduced 1.15%
3,010 $346 Million
Q4 2023

Feb 01, 2024

BUY
$92.27 - $101.54 $280,962 - $309,189
3,045 New
3,045 $307,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Sentry LLC Portfolio

Follow Sentry LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentry LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sentry LLC with notifications on news.